Trials / Completed
CompletedNCT00636662
FLU A+B Nasal Swab Clinical Study
Evaluation of the RAMP FLU A+B Test Versus Viral Culture Using Clinical Nasal Swab Samples From Patients With Suspected Influenza Infections
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (actual)
- Sponsor
- Response Biomedical Corp. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study is to obtain clearance for the nasal swab sample type by demonstrating the performance characteristics of the FLU A+B Test versus standard laboratory culture for Influenza A and B viruses using nasal swab samples.
Detailed description
Patients exhibiting symptoms of influenza enrolled in a fashion that confidentiality of all personal health information is maintained. No patient treatment is affected by enrollment in this trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-invasive diagnostic testing | No patient treatment is altered by enrollment in this trial |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2008-03-14
- Last updated
- 2019-03-27
Locations
5 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00636662. Inclusion in this directory is not an endorsement.